This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
GeneCopoeia
product type :
protein
product name :
Human eukaryotic initiation factor 4A-II
catalog :
hRP-F0835-EF011
quantity :
25 ug
price :
145 USD
product information
Catalog :
hRP-F0835-EF011
volumne :
25 ug
symbol :
EIF4A2
Name :
Human eukaryotic initiation factor 4A-II
description :
ATP-dependent RNA helicase which is a subunit of the eIF4F complex involved in cap recognition and is required for mRNA binding to ribosome. In the current model of translation initiation, eIF4A unwinds RNA secondary structures in the 5'-UTR of mRNAs which is necessary to allow efficient binding of the small ribosomal subunit, and subsequent scanning for the initiator codon.
GenBank Accession :
NM_001967.2
Uniprot Accession :
Q14240
application :
WB, ELISA, IP, antibody production, protein array
Fusion tag :
N-His
Peptide Length :
422aa(including fusion tag)
Molecular Weight :
48.3kDa(including fusion tag)
pI :
6
price :
145 USD
company information

GeneCopoeia
9620 Medical Center Drive
Rockville, MD 20850
Rockville, MD 20850
inquiry@genecopoeia.com
www.genecopoeia.com1-301-762-0888
headquarters: USA
GeneCopoeia offers the largest collection of expression-ready ORF cDNA, shRNA and miRNA clones. Available in a wide collection of lentiviral and non-viral expression vectors with a variety of fusion tags and reporters including fluorescent, solubility, purification and multi-functional tags. Explore the fully sequenced and expression-ready clone collections here.
Pre-validated gene-specific and miRNA qPCR primers are also available with reaction master mix reagents for quantitative analyses of gene or miRNA specific expression. SYBR Green® based qPCR mix kits together with pre-validated primers provide universal qPCR reaction conditions and robust qPCR data. Learn more about qPCR mix and primers.
Save time and publish faster on the GeneCopoeia Expressway to Discovery& number 8482;.
questions and comments
